Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin
about
Venous thromboembolic diseaseDirect thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.Heparin-dependent platelet factor 4 antibodies and the impact of renal function on clinical outcomes: a retrospective study in hospitalized patients.Current concepts review: heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: present and future.Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesTreatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Management of heparin-induced thrombocytopenia.Apixaban as an alternate oral anticoagulant for the management of patients with heparin-induced thrombocytopenia.Anticoagulant failure in coagulopathic patients: PTT confounding and other pitfalls.The challenge of bleeding in antiphospholipid antibody-positive patients.Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trialMonitoring of Argatroban and Lepirudin.On the dosing of lepirudin.Superficial vein thrombosis.
P2860
Q24631121-8EDDB1BD-07A3-4570-A29A-F06663EBF09EQ33373700-9E90EFA2-0FF2-4A46-BC02-78F09B79845AQ33381429-C69C0537-1C75-4664-9826-A8DE577B0335Q33382108-6125A4A0-96CE-4649-BD3E-C8B336FF7977Q33394188-BA55D192-04C3-4876-BA68-BB12BDF94E52Q33399576-5E357FFE-DA2A-41C6-B998-A79EFF56A6EDQ33399580-4C91B8EE-CBCC-48A6-B10F-F73405C04825Q33400573-B3A02520-C108-4438-B1C0-39554C645826Q33408471-0D8EA835-006B-46C2-9CE1-DCC0D90118EAQ33409966-5C918EFD-2ACF-4649-8EA8-F24C3E8D0339Q33419972-9F1E9D66-4714-442E-9B8C-E75975C0014DQ33427441-D6BEAC9D-40D8-4FD4-9B82-41FE572B623FQ33440268-22F91173-2ECB-417E-9578-78C0C4545391Q42942412-7E5CE9A6-31A5-4069-931E-2C8E41287BA1Q43905870-0FB1825F-BEFF-4E80-9A6D-8544EB9A004F
P2860
Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin
description
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im September 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: September 2006)
@en
vedecký článok (publikovaný 2006/09/01)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/09/01)
@nl
наукова стаття, опублікована у вересні 2006
@uk
مقالة علمية (نشرت في سبتمبر 2006)
@ar
name
Predictive factors for thrombo ...... topenia treated with lepirudin
@ast
Predictive factors for thrombo ...... topenia treated with lepirudin
@en
Predictive factors for thrombo ...... topenia treated with lepirudin
@nl
type
label
Predictive factors for thrombo ...... topenia treated with lepirudin
@ast
Predictive factors for thrombo ...... topenia treated with lepirudin
@en
Predictive factors for thrombo ...... topenia treated with lepirudin
@nl
prefLabel
Predictive factors for thrombo ...... topenia treated with lepirudin
@ast
Predictive factors for thrombo ...... topenia treated with lepirudin
@en
Predictive factors for thrombo ...... topenia treated with lepirudin
@nl
P2093
P1433
P1476
Predictive factors for thrombo ...... topenia treated with lepirudin
@en
P2093
Anne Bauters
Bernard Tardy
Brigitte Tardy-Poncet
Christine Mouton
Dominique François
Emmanuel de Maistre
Evelyne Racadot
Fabienne Dutrillaux
Françoise Boelhen
Françoise Nguyen
P304
P356
10.1182/BLOOD-2006-02-001057
P407
P577
2006-09-01T00:00:00Z